• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Proton pump inhibitor use in pediatric patients may increase fracture risk

byJack LennonandRavi Shah, MD MBA
April 3, 2020
in Gastroenterology, Pediatrics, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

Airway impedance may aid diagnosis of gastroesophageal reflux and aspiration in children

Heliobacter pylori eradication significantly reduces the risk of short-term hospitalization in patients taking low dose aspirin

1. The use of proton pump inhibitors (PPIs) in a large pediatric cohort resulted in a small but statistically significant increase in fracture risk compared to children who were not using PPIs.

Evidence Rating Level: 2 (Good)

Proton pump inhibitors (PPIs) are the primary treatment for gastric acid-related disorders in children, despite this treatment being predominantly rooted in expert opinion rather than empirical data. Little is known related to their safety in pediatric populations yet have been prescribed at an increasing rate over recent years. This Sweden-wide register-based cohort study investigated the association between PPI use and fracture risk in a pediatric population – one known to be at risk for fractures. This study also engaged in a direct comparison of PPI and histamine-2 receptor antagonists (H2RA). PPIs included omeprazole, esomeprazole, pantoprazole, rabeprazole, and lansoprazole. The target population was children under the age of 18 years during the study period of July 1, 2006 to December 31, 2016. Each child undergoing PPI treatment was matched with 30 non-PPI children. The final cohort was based on a 1:1 propensity score match and age groups of two-year bands. Children with organ transplant, cancer, congenital skeletal malformation, trauma-associated fracture in past 10 years, liver failure, and severe fractures were excluded. This resulted in a total of 115,933 child pairs with a mean (SD) follow-up period of 2.2 (1.6) years. During follow-up, more fractures were identified among the PPI group than the non-PPI group (difference 1.9 events per 1,000 person-years, HR 1.08, 95% CI 1.06 to 1.15). While no differences were found between groups for head or spine fractures, PPIs were associated with elevated risk of lower-limb fractures (HR 1.19, 95% CI 1.10 to 1.29), upper-limb fractures (HR 1.08, 95% CI 1.03 to 1.13), and other fractures (HR 1.51, 95% CI 1.16 to 1.97). When focusing on PPI use duration, the categories were ≤30 days (HR 1.08, 95% CI 1.03 to 1.13), 31 to 364 days (HR 1.14, 95% CI 1.09 to 1.20), and ≥365 days (HR 1.34, 95% CI 1.13 to 1.58). High-dimensional propensity score matching resulted in a consistent association (HR 1.10, 95% CI 1.06 to 1.15). Comparisons of PPI and H2RA did not reach statistical significance (HR 1.06, 95% CI 0.97 to 1.15). While relatively small, this study suggests statistically significant differences in fracture risk between children who are exposed to PPI treatment compared to those who are not. This suggests that physicians must carefully weigh the costs and benefits when considering PPI treatment among pediatric populations.

Click to read the study in JAMA Pediatrics

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: fractureGERDH2 receptor antagonistsproton pump inhibitor (PPI)
Previous Post

#VisualAbstract: A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents

Next Post

Increased mental health concerns in Latino adolescents exposed to detention or deportation

RelatedReports

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma
StudyGraphics

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

January 24, 2023
Quick Take: Comparison of Laparoscopic 270 Degree Posterior Partial Fundoplication vs Total Fundoplication for the Treatment of Gastroesophageal Reflex Disease: a Randomized Clinical Trial  
Chronic Disease

Airway impedance may aid diagnosis of gastroesophageal reflux and aspiration in children

December 8, 2022
Ultrasound enhances gastrointestinal absorption of drugs at low frequencies
Chronic Disease

Heliobacter pylori eradication significantly reduces the risk of short-term hospitalization in patients taking low dose aspirin

November 16, 2022
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Infectious Disease

Chlorhexidine and povidone-iodine equally effective for skin antisepsis of open fractures undergoing surgical fixation

October 25, 2022
Next Post
AAP reaffirms support for adolescents’ rights to confidential reproductive care

Increased mental health concerns in Latino adolescents exposed to detention or deportation

Quick Take: State Gun Laws, Gun Ownership, and Mass Shootings in the US: Cross-Sectional Time Series

Non-trauma centers often in closer proximity to mass shootings than trauma centers

Many new pediatric asthma cases attributable to obesity

Liraglutide adjuvant therapy found to increase weight loss in obese adolescents

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options